Immunohistological analysis reveals IgG1-dominant immunophenotype of tubulointerstitial nephritis unassociated with IgG4-related diseases
International Urology and Nephrology · 2024
DOI: 10.1007/s11255-024-03966-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Toshiki Hyodo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan. bari1049@med.kobe-u.ac.jp. Hauptthemen laut MEDLINE: Nephritis, Interstitial, Immunoglobulin G, Immunoglobulin G4-Related Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kobe University.
Abstract (Originalsprache)
Purpose
Tubulointerstitial nephritis (TIN) has various etiologies, including IgG4-related disease (IgG4-RD), autoimmune diseases, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), and others. IgG4-positive plasma cell infiltration can occasionally be found in TIN unrelated to IgG4-RD. Therefore, there may be problems with usage of IgG4 immunostaining to differentiate between TIN with and TIN without IgG4-RD. This study aimed to compare the proportion of plasma cells that are positive for each IgG subclass and to clarify the predominant IgG subclass trends and clinical characteristics associated with IgG4-RD and non-IgG4-related interstitial nephritis.
Methods
The study enrolled 44 cases of TIN: 6 of IgG4-RD, 8 of autoimmune disease, 9 of AAV, and 21 of unknown disease group. In addition to clinical characteristics, IgG subclass composition of interstitial plasma cells was evaluated among 4 groups by immunohistochemistry.
Results
IgG1 was the predominant IgG subclass in TIN unrelated to IgG4-RD. In the IgG4-RD group, the IgG subclass rate was high in both IgG1 and IgG4. The rate of average IgG4-positive cells was significantly lower in the autoimmune disease group and unknown disease group compared with the IgG4-RD group.
Conclusion
The present study revealed IgG1-dominant immune profiles of TIN unrelated to IgG4-RD. Further investigation is required to elucidate the clinicopathological differences between IgG1-dominant and IgG4-dominant groups in IgG4-RD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan. bari1049@med.kobe-u.ac.jp.
- Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Diagnostic Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
- Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
- Clinical Research Center, Takatsuki General Hospital, Takatsuki, Japan.
Förderung
- Kobe University
Zitieren
APA
Hyodo, T., Hara, S., Goto, S., Fujii, H., Nishi, S., Horinouchi, T., Nozu, K., Yoshikawa, N., Yoshimoto, A., & Itoh, T. (2024). Immunohistological analysis reveals IgG1-dominant immunophenotype of tubulointerstitial nephritis unassociated with IgG4-related diseases. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-03966-1
Vancouver
Hyodo T, Hara S, Goto S, Fujii H, Nishi S, Horinouchi T, et al. Immunohistological analysis reveals IgG1-dominant immunophenotype of tubulointerstitial nephritis unassociated with IgG4-related diseases. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-03966-1
BibTeX
@article{Hyodo2024,
author = {Hyodo, Toshiki and Hara, Shigeo and Goto, Shunsuke and Fujii, Hideki and Nishi, Shinichi and Horinouchi, Tomoko and Nozu, Kandai and Yoshikawa, Norishige and Yoshimoto, Akihiro and Itoh, Tomoo},
title = {Immunohistological analysis reveals IgG1-dominant immunophenotype of tubulointerstitial nephritis unassociated with IgG4-related diseases},
journal = {International Urology and Nephrology},
year = {2024},
doi = {10.1007/s11255-024-03966-1}
}
EUVIMED